162 related articles for article (PubMed ID: 37983556)
1. Natural Terpenes Inhibit the Cytopathogenicity of
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Chem Neurosci; 2023 Dec; 14(23):4105-4114. PubMed ID: 37983556
[No Abstract] [Full Text] [Related]
2. Nanoparticle-Terpene Fusion: A Game-Changer in Combating Primary Amoebic Meningoencephalitis Caused by
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Omega; 2024 Mar; 9(10):11597-11607. PubMed ID: 38497026
[TBL] [Abstract][Full Text] [Related]
3. The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Alawfi BS; Khan NA
Parasitol Res; 2023 Nov; 122(11):2539-2548. PubMed ID: 37665414
[TBL] [Abstract][Full Text] [Related]
4. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
5. Identification and characterization of novel marine oxasqualenoid yucatecone against Naegleria fowleri.
Arberas-Jiménez I; Cen-Pacheco F; Chao-Pellicer J; Sifaoui I; Rizo-Liendo A; Morales EQ; Daranas AH; Díaz-Marrero AR; Piñero JE; Fernández JJ; Lorenzo-Morales J
Int J Parasitol Drugs Drug Resist; 2023 Aug; 22():61-71. PubMed ID: 37270868
[TBL] [Abstract][Full Text] [Related]
6. Anti-amoebic effects of synthetic acridine-9(10H)-one against brain-eating amoebae.
Ahmed U; Manzoor M; Qureshi S; Mazhar M; Fatima A; Aurangzeb S; Hamid M; Khan KM; Khan NA; Rashid Y; Anwar A
Acta Trop; 2023 Mar; 239():106824. PubMed ID: 36610529
[TBL] [Abstract][Full Text] [Related]
7. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Anti-Infective Value of Inuloxin A Isolated from
Zeouk I; Sifaoui I; Rizo-Liendo A; Arberas-Jiménez I; Reyes-Batlle M; L Bazzocchi I; Bekhti K; E Piñero J; Jiménez IA; Lorenzo-Morales J
ACS Chem Neurosci; 2021 Jan; 12(1):195-202. PubMed ID: 33296597
[TBL] [Abstract][Full Text] [Related]
9. A Fluorometric Assay for the
Arberas-Jiménez I; Rizo-Liendo A; Sifaoui I; Chao-Pellicer J; Piñero JE; Lorenzo-Morales J
Microbiol Spectr; 2022 Aug; 10(4):e0051522. PubMed ID: 35862997
[TBL] [Abstract][Full Text] [Related]
10. Cyanomethyl Vinyl Ethers Against
Chao-Pellicer J; Arberas-Jiménez I; Delgado-Hernández S; Sifaoui I; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
ACS Chem Neurosci; 2023 Jun; 14(11):2123-2133. PubMed ID: 37167960
[No Abstract] [Full Text] [Related]
11. Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris.
Siddiqui R; Mungroo MR; Anuar TS; Alharbi AM; Alfahemi H; Elmoselhi AB; Khan NA
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740156
[TBL] [Abstract][Full Text] [Related]
12. trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Shah MR; Siddiqui R
ACS Chem Neurosci; 2019 Jun; 10(6):2692-2696. PubMed ID: 30970208
[TBL] [Abstract][Full Text] [Related]
13. Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri.
Burri DC; Gottstein B; Zumkehr B; Hemphill A; Schürch N; Wittwer M; Müller N
Microbiology (Reading); 2012 Oct; 158(Pt 10):2652-2660. PubMed ID: 22878396
[TBL] [Abstract][Full Text] [Related]
14. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
Peroutka-Bigus N; Bellaire BH
J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
[TBL] [Abstract][Full Text] [Related]
15. The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis.
Ženíšková K; Mach J; Arbon D; Štursa J; Werner L; Zoltner M; Sutak R
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0150622. PubMed ID: 36688657
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis.
Sarink MJ; Tielens AGM; Verbon A; Sutak R; van Hellemond JJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513800
[TBL] [Abstract][Full Text] [Related]
17. Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae.
Akbar N; Kaman WE; Sarink M; Nazmi K; Bikker FJ; Khan NA; Siddiqui R
ACS Omega; 2022 Aug; 7(33):28797-28805. PubMed ID: 36033708
[No Abstract] [Full Text] [Related]
18. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
19. Fighting with brain-eating amoeba: challenges and new insights to open a road for the treatment of Naegleria fowleri infection.
Gajula SN; Nalla LV
Expert Rev Anti Infect Ther; 2023; 21(12):1277-1279. PubMed ID: 37750324
[No Abstract] [Full Text] [Related]
20. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
